Linnaeus Therapeutics, Inc.

New Filing

CIK: 0001752026·Biotechnology·DELAWARE·Filed: Jan 26, 2023

Total Offering

$3,088,234

Amount Sold

$3,088,234

Investors

8

First Sale

Jan 24, 2023

Offering Details

Type: Equity
Exemptions: Rule 506(b), Section 4(a)(5)
Entity Type: Corporation
Non-Accredited Investors: No

Related Persons

Name	Role
Patrick T. Mooney	Related Person
Todd T. Thomson	Related Person
Nicholas T. Iatropoulos	Related Person
Michael D. Poisel	Related Person

Company

Linnaeus Therapeutics, Inc.

30 WASHINGTON AVENUE, SUITE F

HADDONFIELD, NJ, 08033

856-433-1500

SEC Filing

0001752026-23-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.